Basics Eton Pharmaceuticals, Inc. Common Stock IPO Date: November 13, 2018 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $497.47M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 2.73% Avg Daily Range (30 D): $0.48 | 2.41% Avg Daily Range (90 D): $0.35 | 2.05% Institutional Daily Volume Avg Daily Volume: .2M Avg Daily Volume (30 D): .28M Avg Daily Volume (90 D): .31M Trade Size Avg Trade Size (Sh.): 113 Avg Trade Size (Sh.) (30 D): 53 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 66 Avg Inst. Trade: $1.74M Avg Inst. Trade (30 D): $.9M Avg Inst. Trade (90 D): $1.82M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.41M Avg Closing Trade (30 D): $.94M Avg Closing Trade (90 D): $2.18M Avg Closing Volume: 217.98K     News May 9, 2024 @ 8:01 PM Eton Pharmaceuticals Reports First Quarter 2024 Fi... Source: Eton Pharmaceuticals May 1, 2024 @ 8:05 PM Eton Pharmaceuticals to Present at the Citizens JM... Source: Eton Pharmaceuticals Apr 30, 2024 @ 11:00 AM Eton Pharmaceuticals Announces Submission to FDA o... Source: Eton Pharmaceuticals Apr 29, 2024 @ 8:30 PM Eton Pharmaceuticals to Report First Quarter 2024 ... Source: Eton Pharmaceuticals Mar 22, 2024 @ 6:00 AM Eton Pharmaceuticals Announces Acquisition of PKU... Source: Eton Pharmaceuticals Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.16 $-.1 $-.06 Diluted EPS Revenue $ 58.18M $ 18.93M $ 17.28M Gross Profit $ 34.56M $ 11.92M $ 9.86M Net Income / Loss $ -4.13M $ -2.59M $ -1.57M Operating Income / Loss $ -.81M $ -1.48M $ -.47M Cost of Revenue $ 23.62M $ 7M $ 7.42M Net Cash Flow $ -2.76M $ M $ M PE Ratio